47,191 Shares in Maximus, Inc. $MMS Acquired by Candriam S.C.A.

Candriam S.C.A. purchased a new position in Maximus, Inc. (NYSE:MMS) during the first quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The fund purchased 47,191 shares of the health services provider’s stock, valued at approximately $3,218,000. Candriam S.C.A. owned 0.08% of Maximus at the end of the most recent quarter.

Other hedge funds also recently modified their holdings of the company. Caitong International Asset Management Co. Ltd raised its holdings in shares of Maximus by 17,533.3% in the 1st quarter. Caitong International Asset Management Co. Ltd now owns 529 shares of the health services provider’s stock worth $36,000 after purchasing an additional 526 shares during the period. UMB Bank n.a. raised its holdings in shares of Maximus by 70.2% in the 1st quarter. UMB Bank n.a. now owns 606 shares of the health services provider’s stock worth $41,000 after purchasing an additional 250 shares during the period. GAMMA Investing LLC raised its holdings in shares of Maximus by 67.1% in the 1st quarter. GAMMA Investing LLC now owns 732 shares of the health services provider’s stock worth $50,000 after purchasing an additional 294 shares during the period. NBC Securities Inc. raised its holdings in shares of Maximus by 114,900.0% in the 1st quarter. NBC Securities Inc. now owns 1,150 shares of the health services provider’s stock worth $78,000 after purchasing an additional 1,149 shares during the period. Finally, Blue Trust Inc. raised its holdings in shares of Maximus by 32.8% in the 1st quarter. Blue Trust Inc. now owns 1,228 shares of the health services provider’s stock worth $84,000 after purchasing an additional 303 shares during the period. Institutional investors own 97.21% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, Wall Street Zen cut shares of Maximus from a “buy” rating to a “hold” rating in a report on Thursday, May 15th. One investment analyst has rated the stock with a Buy rating, According to data from MarketBeat.com, the company currently has a consensus rating of “Buy” and an average target price of $90.00.

Maximus Stock Up 1.8%

MMS opened at $86.9260 on Friday. The company has a fifty day moving average price of $74.51 and a 200-day moving average price of $71.07. The firm has a market capitalization of $4.90 billion, a P/E ratio of 16.01 and a beta of 0.60. The company has a debt-to-equity ratio of 0.91, a current ratio of 2.27 and a quick ratio of 2.27. Maximus, Inc. has a one year low of $63.77 and a one year high of $93.94.

Maximus (NYSE:MMS) last released its quarterly earnings results on Thursday, August 7th. The health services provider reported $2.16 EPS for the quarter, beating analysts’ consensus estimates of $1.39 by $0.77. Maximus had a net margin of 5.83% and a return on equity of 24.44%. The firm had revenue of $1.35 billion during the quarter, compared to analyst estimates of $1.29 billion. During the same period in the previous year, the business earned $1.74 EPS. The business’s revenue for the quarter was up 2.5% on a year-over-year basis. Maximus has set its FY 2025 guidance at 7.350-7.550 EPS. Equities research analysts expect that Maximus, Inc. will post 6.15 earnings per share for the current fiscal year.

Maximus Announces Dividend

The firm also recently declared a quarterly dividend, which will be paid on Sunday, August 31st. Shareholders of record on Friday, August 15th will be paid a $0.30 dividend. The ex-dividend date of this dividend is Friday, August 15th. This represents a $1.20 annualized dividend and a yield of 1.4%. Maximus’s payout ratio is currently 22.10%.

Insiders Place Their Bets

In other news, Director Gayathri Rajan sold 7,913 shares of the company’s stock in a transaction dated Friday, May 30th. The shares were sold at an average price of $72.38, for a total transaction of $572,742.94. Following the completion of the transaction, the director directly owned 14,205 shares of the company’s stock, valued at approximately $1,028,157.90. This represents a 35.78% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which is accessible through this hyperlink. 1.60% of the stock is owned by corporate insiders.

About Maximus

Maximus, Inc operates as a provider of government services in the United States and internationally. It operates through three segments: U.S. Federal Services, U.S. Services, and Outside the U.S. The U.S. Services segment offers program eligibility support and enrollment; centralized multilingual customer contact centers, multichannel, and digital self-service options for enrollment; application assistance and independent health plan choice counseling; beneficiary outreach, education, eligibility, enrollment, and redeterminations; and person-centered independent disability, long-term sick, and other health assessments.